Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Dean22April
    Junior Member
    • Dec 2017
    • 1

    #1

    Have I written this correctly?

    Hi, I'm in a group investigating gene editing in wheat using CRISPR/Cas9 and we have the Illumina MiSeq sequencing results but I am unsure how to succinctly present the analysis we did (I have next to no understanding of bioinformatics- I did not do the analysis myself but am writing it up for an undergraduate report).

    I was therefore wondering if the following made sense (I have all the individual commands which I will put in the supplementary materials). This is my best shot so far (I've had to anonymise names until results are published):

    Initial sequence quality was checked using FastQCv0.10.1. Illumina adaptor sequences were then removed using cutadapt version 1.14. Reads were then trimmed by quality score using fastq-mcf (Version: 1.05.676). A custom perl script was then run on reads to separate samples used in this study from ----- ------’ (University of ****, UK) samples. To ensure the bowtie2 aligner could be used, pairfq (version 0.17.0) was used to create new fastq files that only contained mate pair reads. Bowtie2 index for reference sequences was then built. Sequence alignments for each set of reads was then set up and sam tools were used to convert sam (Sequence Alignment Map) alignment files to a binary bamfile, this was then sorted and a bam index was created. Bam files were visualised using the Tablet software. Refer to supplementary information for individual commands.


    Does this make sense? What else (and where in that paragraph) should I have included?

    Any help would be extremely well appreciated.

    Thank you so much
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    For an undergraduate report that description is fine.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...